Suppr超能文献

释放一氧化氮的壳寡糖对黏液黏弹性的作用

Role of Nitric Oxide-Releasing Chitosan Oligosaccharides on Mucus Viscoelasticity.

作者信息

Reighard Katelyn P, Ehre Camille, Rushton Zachary L, Ahonen Mona Jasmine R, Hill David B, Schoenfisch Mark H

机构信息

Department of Chemistry, University of North Carolina-Chapel Hill, 131 South Road, Chapel Hill, North Carolina 27599, United States.

Marsico Lung Institute, University of North Carolina-Chapel Hill, 125 Mason Farm Road, Chapel Hill, North Carolina 27599, United States.

出版信息

ACS Biomater Sci Eng. 2017;3(6):1017-1026. doi: 10.1021/acsbiomaterials.7b00039. Epub 2017 May 15.

Abstract

Nitric oxide (NO)-releasing chitosan oligosaccharides were modified with ester functional groups to examine how the mucoadhesive nature of the scaffold impacts the ability of NO to degrade mucins from human bronchial epithelial cell cultures and clinical sputum samples collected from patients with cystic fibrosis (CF). Agarose gel electrophoresis experiments indicated that the mucoadhesive NO-releasing chitosan oligosaccharides degraded both the purified mucins and sputum, while control scaffolds (without NO release or mucoadhesive ligands) had no effect on mucin structure. Microscopic observations of sputum treated with the mucoadhesive NO-releasing chitosan oligosaccharide confirmed degradation of the mucin and DNA networks. Similarly, the viscosity and elasticity of sputum were reduced upon treatment with the mucoadhesive NO-releasing chitosan, demonstrating the potential utility of these NO-releasing scaffolds as mucolytic agents.

摘要

用酯官能团修饰释放一氧化氮(NO)的壳寡糖,以研究支架的黏膜黏附特性如何影响NO从人支气管上皮细胞培养物和从囊性纤维化(CF)患者收集的临床痰液样本中降解黏蛋白的能力。琼脂糖凝胶电泳实验表明,具有黏膜黏附性的释放NO的壳寡糖可降解纯化的黏蛋白和痰液,而对照支架(不释放NO或无黏膜黏附配体)对黏蛋白结构无影响。对用具有黏膜黏附性的释放NO的壳寡糖处理的痰液进行显微镜观察,证实了黏蛋白和DNA网络的降解。同样,用具有黏膜黏附性的释放NO的壳聚糖处理后,痰液的黏度和弹性降低,证明了这些释放NO的支架作为黏液溶解剂的潜在用途。

相似文献

1
Role of Nitric Oxide-Releasing Chitosan Oligosaccharides on Mucus Viscoelasticity.
ACS Biomater Sci Eng. 2017;3(6):1017-1026. doi: 10.1021/acsbiomaterials.7b00039. Epub 2017 May 15.
2
Mucolytic activity of bacterial and human chitinases.
Biochim Biophys Acta. 2007 May;1770(5):839-46. doi: 10.1016/j.bbagen.2007.01.011. Epub 2007 Feb 1.
3
Antibiofilm and mucolytic action of nitric oxide delivered via gas or macromolecular donor using in vitro and ex vivo models.
J Cyst Fibros. 2020 Nov;19(6):1004-1010. doi: 10.1016/j.jcf.2020.03.004. Epub 2020 Mar 21.
4
Nitric oxide-releasing alginates as mucolytic agents.
ACS Biomater Sci Eng. 2019 Jul 8;5(7):3409-3418. doi: 10.1021/acsbiomaterials.9b00482. Epub 2019 May 24.
6
A New Class of Safe Oligosaccharide Polymer Therapy To Modify the Mucus Barrier of Chronic Respiratory Disease.
Mol Pharm. 2016 Mar 7;13(3):863-72. doi: 10.1021/acs.molpharmaceut.5b00794. Epub 2016 Feb 16.
8
Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):710-4. doi: 10.1164/ajrccm.157.3.9703059.
9
Oxidation increases mucin polymer cross-links to stiffen airway mucus gels.
Sci Transl Med. 2015 Feb 25;7(276):276ra27. doi: 10.1126/scitranslmed.3010525.
10
Gel-forming mucin interactome drives mucus viscoelasticity.
Adv Colloid Interface Sci. 2018 Feb;252:69-82. doi: 10.1016/j.cis.2017.12.005. Epub 2017 Dec 28.

引用本文的文献

1
Biopolymeric Inhalable Dry Powders for Pulmonary Drug Delivery.
Pharmaceuticals (Basel). 2024 Dec 4;17(12):1628. doi: 10.3390/ph17121628.
2
Inhaled drug delivery for the targeted treatment of asthma.
Adv Drug Deliv Rev. 2023 Jul;198:114858. doi: 10.1016/j.addr.2023.114858. Epub 2023 May 12.
3
Altering the viscoelastic properties of mucus-grown biofilms affects antibiotic susceptibility.
Biofilm. 2023 Jan 21;5:100104. doi: 10.1016/j.bioflm.2023.100104. eCollection 2023 Dec.
5
Stearic acid modified nano CuMOFs used as a nitric oxide carrier for prolonged nitric oxide release.
RSC Adv. 2022 Jan 17;12(4):2383-2390. doi: 10.1039/d1ra08066k. eCollection 2022 Jan 12.
9
Therapeutic Delivery of Nitric Oxide Utilizing Saccharide-Based Materials.
ACS Appl Mater Interfaces. 2021 Nov 10;13(44):52250-52273. doi: 10.1021/acsami.1c10964. Epub 2021 Oct 29.
10
NO donors and NO delivery methods for controlling biofilms in chronic lung infections.
Appl Microbiol Biotechnol. 2021 May;105(10):3931-3954. doi: 10.1007/s00253-021-11274-2. Epub 2021 May 3.

本文引用的文献

4
Antibacterial Action of Nitric Oxide-Releasing Chitosan Oligosaccharides against Pseudomonas aeruginosa under Aerobic and Anaerobic Conditions.
Antimicrob Agents Chemother. 2015 Oct;59(10):6506-13. doi: 10.1128/AAC.01208-15. Epub 2015 Aug 3.
5
Kinetic-dependent Killing of Oral Pathogens with Nitric Oxide.
J Dent Res. 2015 Aug;94(8):1092-8. doi: 10.1177/0022034515589314. Epub 2015 Jun 15.
6
The Relationship of Mucus Concentration (Hydration) to Mucus Osmotic Pressure and Transport in Chronic Bronchitis.
Am J Respir Crit Care Med. 2015 Jul 15;192(2):182-90. doi: 10.1164/rccm.201412-2230OC.
7
Anti-Biofilm Efficacy of Dual-Action Nitric Oxide-Releasing Alkyl Chain Modified Poly(amidoamine) Dendrimers.
Mol Pharm. 2015 May 4;12(5):1573-83. doi: 10.1021/acs.molpharmaceut.5b00006. Epub 2015 Apr 15.
8
Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis--where do we stand?
Expert Opin Drug Deliv. 2015 Aug;12(8):1351-74. doi: 10.1517/17425247.2015.1007949. Epub 2015 Feb 2.
9
State of the art, challenges and perspectives in the design of nitric oxide-releasing polymeric nanomaterials for biomedical applications.
Biotechnol Adv. 2015 Nov 1;33(6 Pt 3):1370-9. doi: 10.1016/j.biotechadv.2015.01.005. Epub 2015 Jan 28.
10
Structure of chitosan determines its interactions with mucin.
Biomacromolecules. 2014 Oct 13;15(10):3550-8. doi: 10.1021/bm5007954. Epub 2014 Sep 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验